Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near Boston, MA

82 studies for Prostate Cancer are recruiting at 116 sites within 50 miles of Boston, Massachusetts, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near Boston.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near Boston

Showing the 50 nearest of 82 studies.
  1. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    NCT05946213

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Brigham and Women's Hospital (Boston, MA); Dana-Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  2. International Registry for Men With Advanced Prostate Cancer (IRONMAN)

    NCT03151629

    • Observational
    • Ages 21 years and older
    • Sex: Male

    Nearest sites: Dana-Farber Cancer Institute (Boston, MA); University of Massachusetts Memorial Medical Center (Worcester, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    NCT03972657

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Massachusetts General Hospital (Boston, MA); Lifespan Cancer Institute (Providence, RI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  4. Stereotactic Magnetic Resonance Guided Radiation Therapy

    NCT04115254

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Brigham & Women's Hospital (Boston, MA); Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. Serial MRI Scans During Radiation Therapy

    NCT04188535

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Brigham and Women Hospital (Boston, MA); Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. Jump: MR Simulation For Radiation Therapy Master Protocol

    NCT04545957

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Brigham and Women Hospital (Boston, MA); Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest sites: Dana Farber Cancer Institute (Boston, MA); Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

    NCT05652686

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Dana-Farber Cancer Institute (Boston, MA); Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  9. RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

    NCT05765500

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Dana-Farber Cancer Institute (Boston, MA); Dana-Farber Cancer Institute at Foxborough (Foxborough, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    NCT05919264

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Dana Farber Cancer Institute (Boston, MA); Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

    NCT05939414

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: Beth Israel Deaconess Med Ctr (Boston, MA); Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Dana-Farber Cancer Institute (Boston, MA); Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

    NCT06062745

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Brigham and Womens Hospital (Boston, MA); Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

    NCT06099093

    • Phase 4
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Brigham and Womens Hospital (Boston, MA); Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. CV CARE: CardioVascular Care in PC Patients

    NCT06202820

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Brigham and Women's Hospital (Boston, MA); Dana-Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer

    NCT06398639

    • Interventional
    • Ages 40 to 69 years
    • Sex: Male
    • Accepts healthy volunteers

    Nearest sites: Brigham and Women's Hospital (Boston, MA); Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

    NCT06780670

    • Phase 2/3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: Beth Israel Deaconess Medical Center (Boston, MA); Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

    NCT06784193

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Dana-Farber Cancer Institute (Boston, MA); Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  19. Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

    NCT06855277

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: Beth Israel Deaconess Med Center (Boston, MA); Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  20. Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

    NCT06862856

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Dana Farber Cancer Institute (Boston, MA); Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  21. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    NCT06925737

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Beth Israel Deaconess Medical Center ( Site 0043) (Boston, MA); Dana Farber Cancer Institute ( Site 0012) (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  22. Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

    NCT07181161

    • Phase 1/2
    • Ages 18 to 130 years
    • Sex: Male

    Nearest sites: Research Site (Boston, MA); Research Site (Providence, RI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  23. A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

    NCT07244341

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Beth Isreal Deaconess Medical Center (Boston, MA); Dana Farber Cancer Institute (Newton, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  24. Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)

    NCT07427043

    • Phase 3
    • Ages 45 years and older
    • Sex: Male

    Nearest sites: Brigham and Women's Faulkner Hospital (Boston, MA); Brigham and Women's Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  25. Prostate Active Surveillance Study

    NCT00756665

    • Observational
    • Ages 21 years and older
    • Sex: Male

    Nearest site: Beth Israel Deaconess Medical Center/Harvard Medical School (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy

    NCT01961713

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Massachsuetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

    NCT04104776

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

    NCT04363164

    • Phase 2
    • Ages 18 to 90 years
    • Sex: Male

    Nearest site: Dana-Faber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

    NCT04373564

    • Phase 4
    • Ages 18 to 64 years
    • Sex: All

    Nearest site: Massachussets General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

    NCT04472338

    • Observational
    • Ages 40 years and older
    • Sex: Male
    • Accepts healthy volunteers

    Nearest site: Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Precision-Based Genomics in Prostate Cancer

    NCT04706663

    • Observational
    • Ages 18 to 120 years
    • Sex: Male

    Nearest site: Dana Farber Cancer Institute, Boston, MA (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

    NCT04787744

    • Phase 2/3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

    NCT04812366

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Dana-Farber Cancer Institute / Beth Israel Deaconess Medical Center (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

    NCT04890613

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. Prostate Cancer Genetic Risk Evaluation and Screening Study

    NCT05129605

    • Observational
    • Ages 35 to 74 years
    • Sex: Male

    Nearest site: Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Clinical Trial of Approaches to Prostate Cancer Surgery

    NCT05155501

    • Interventional
    • Ages 40 to 80 years
    • Sex: Male

    Nearest site: Beth Israel Deaconess Medical Center (BIDMC) (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Exelixis Clinical Site #7 (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. Video Education With Result Dependent dIsclosure

    NCT05225428

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy

    NCT05327465

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. Comprehensive Outcomes for After Cancer Health

    NCT05349227

    • Interventional
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

    NCT05417594

    • Phase 1/2
    • Ages 18 to 130 years
    • Sex: All

    Nearest site: Research Site (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)

    NCT05926102

    • Interventional
    • Ages 55 to 69 years
    • Sex: Male
    • Accepts healthy volunteers

    Nearest site: VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial

    NCT06040125

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Brigham and Women's Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

    NCT06067841

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Dana-Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

    NCT06239194

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

    NCT06274047

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Dana-Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. MRI Guided Prostate Biopsy

    NCT06302595

    • Interventional
    • Ages 30 years and older
    • Sex: Male

    Nearest site: Brigham and Women's Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

    NCT06395519

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

    NCT06451497

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Dana Farber Cancer Institute (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    NCT06465069

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.